1201902-01-3 Usage
Structure
Quinazoline derivative with a 4-methoxyphenyl group and a 2-methyl-1H-imidazol-1-yl group attached to the quinazoline ring
Potential drug candidate
For the treatment of various diseases, including cancer and neurological disorders
Unique structure and functional groups
Make it a promising target for pharmaceutical research and development
Important subject of study
In the field of medicinal chemistry
Check Digit Verification of cas no
The CAS Registry Mumber 1201902-01-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,9,0 and 2 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1201902-01:
(9*1)+(8*2)+(7*0)+(6*1)+(5*9)+(4*0)+(3*2)+(2*0)+(1*1)=83
83 % 10 = 3
So 1201902-01-3 is a valid CAS Registry Number.
1201902-01-3Relevant articles and documents
6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW MAO INHIBITORS AND IMIDAZOLINE RECEPTOR LIGANDS
-
Page/Page column 27, (2010/01/12)
The present invention is directed to 6-(1H-imidazo-1-yl)-2-aryl and 2-heteroaryl quinazoline and quinolines derivatives, compounds of formula (I), their pharmaceutical acceptable salts and solvates and corresponding pharmaceutical compositions, that acts